A SAFE vaccine against dengue and dengue haemorrhagic fever has been developed by scientists at Bangkok's Mahidol University, who have been working on a WHO-sponsored research programme for the last 13 years.
Dengue is transmitted by the bite of the infective Aedes aegypti mosquito and is caused by the dengue virus. Numerous types of this infection are now endemic in the tropics. Outbreaks and epidemics threaten more than 85 countries throughout Asia, the Pacific Islands, Africa, Central and South America.
Developed by N Bhamarapravati and his team of researchers, the vaccine has proved to be safe in humans and effective against four strains of the dengue virus in formal clinical trials and will now be tested for efficacy under field conditions.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.